All News

A structured nurse-led clinic can help patients with myeloproliferative neoplasms receive timely support, as well as bridge gaps in symptom reporting.

The FDA approved the Dako Omnis panel to identify patients with colorectal cancer with mismatch repair deficiency.

The GIST treatment landscape has shifted in recent years due to the emergence of new therapies, many of which patients should be aware of.

CURE spoke with an expert about the needs of children in families living with cancer during back-to-school season.

When a family member receives a diagnosis, it can present emotional challenges for children.

Kimberly (Cary) Demirhan discusses the need for more diversity and inclusivity in clinical trials for patients with cancer.

The FDA declined approval of Darzalex Faspro for newly diagnosed, transplant-ineligible multiple myeloma in its current form.

Being diagnosed with a disease like prostate cancer is a very impactful life event, making it vital to have people you love by your side.

CAR-T cell therapies are now being explored for the treatment of solid tumors like gliomas, Dr. Tanja A. Gruber explained in an interview with CURE.

I share how my friendship with advocate Amy Byer Shainman helped me navigate hereditary cancer, showing that real support comes from empath and honesty.

Personalized vaccines are currently being investigated for the treatment of patients with kidney cancer; however, the investigation is still in early stages.

Study finds anti-nausea drug aprepitant boosts distant disease-free and breast cancer-specific survival in early-stage triple-negative breast cancer.

Through three family cancer diagnoses, and my own life-threatening stage 3b lung cancer verdict, family support and reconnection helped support me.

Dr. Rosario Ligresti discussed common signs and symptoms of GIST, as well as highlighted how the treatment landscape has changed in recent years.

The FDA granted breakthrough therapy designation to Ifinatamab deruxtecan for some with extensive-stage small cell lung cancer.

Although GIST can be identified during an endoscopy, according to Dr. Rosario Ligresti, these are still rare tumors that warrant further characterization.

CURE spoke with a clinical social worker about issues faced by families dealing with cancer as kids return to school.

Structured resistance training is safe for breast cancer patients, improving arm muscle and reducing lymphedema during and after treatment.

Although gastrointestinal stromal tumor, or GIST, is a rare type of cancer, between 4,000 and 6,000 people are diagnosed with GIST in the U.S. yearly.

When I was diagnosed with breast cancer, I found strength, support, and hope through friendship and community that carried me through the hardest moments.

For patients undergoing a radical cystectomy, staying active before and after surgery is key, Dr. Janet Kukreja explained.

ctDNA-MRD testing better predicted outcomes versus PET/CT scans for large B-cell lymphoma, leading to NCCN guideline updates for remission assessment.

Natural killer cells, also referred to as NK cells, play several major roles in the body's defense against cancers like renal cell carcinoma.

A new AI precision medicine test is being used to help clinicians better identify a personalized treatment plan to treat patients with prostate cancer.

Breast cancer survivors who lost ≤5% of body weight with diet and exercise experienced greater weight loss, improved function, and less pain with Contrave.

Data show that the cancer vaccine Cylembio plus Keytruda demonstrated clinical improvement in progression-free survival in unresectable/advanced melanoma.

A nationwide survey of patients and caregivers has found educational and financial disparities in brain cancer care.